Navigation Links
Wound Management Technologies, Inc. Announces the Presentation of Evidence Based Clinical Studies at the Symposium on Advanced Wound Care Conference in Dallas
Date:4/23/2009

FORT WORTH, Texas, April 23 /PRNewswire-FirstCall/ -- Wound Care Innovations, LLC, a subsidiary of Wound Management Technologies, Inc., (OTC Bulletin Board: WNDM), announced today that it will exhibit at the 22nd Annual Symposium on Advanced Wound Care and Wound Healing Society (SAWC/WHS) conference in Dallas April 26-29. This conference is regarded industry wide as the premier educational wound-care focused program and has grown to become the largest annual gathering of wound care clinicians in the United States. Pre-registrations numbers indicate that more than 2200 physicians, nurses, therapists, scientists, and other allied healthcare professionals are expected to attend. Oral and poster abstract presentations, pre-and post-conference sessions, and other events offer important information as well as vast networking opportunities. There are 2 abstracts being presented on Wound Care Innovations' advanced wound care collagen product, CellerateRx(R). One abstract is entitled "Emerging Use of Topical Biologics in Limb Salvage: The Role of Activated Collagen in the Multimodality Treatment" and illustrates the biocompatibility of CellerateRx and its effectiveness in multimodality treatments. A second abstract, "Activated Collagen: An Evidence Based Skin Tear Study: Interim Evaluation" shows that the use of CellerateRx increased the efficiency of healing and a majority of the tears or flaps were resolved within one week, with just one application compared to approximately two week with the untreated controls.

"We are particularly excited about this year's SAWC conference," said Cathy Bradshaw, President of Wound Care Innovations. "We recognize the importance of the management of diabetic wounds and the role in limb salvage. Amputation rates are on the rise with devastating consequences to the patient and a drain on the healthcare system. And skin tears represent a major problem in the elderly and compromised patients. Untreated skin tears can serve as a portal of entry for infection and be a source of pain for the patient. Their treatment can have an impact on facilities' resources. We are delighted to have these evidence based abstracts and studies presented which show not only the efficacy of CellerateRx(R) but also its wide range of use in wound care."

About Wound Management Technologies, Inc.:

Wound Management Technologies, Inc. (OTCBB:WNDM), with its corporate headquarters in Fort Worth, Texas, markets and distributes wound care products to the healthcare market under patented technology licensed to the Company. The Company is positioned and seeks to be a leading provider of wound care products. For more information on the Company please visit the Company's Website at www.Celleraterx.com .

"Safe Harbor" Statement: Under The Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the company's expectations with regard to the future impact on the company's results from new products in development are "forward-looking statements," within the meaning of the Private Securities Litigation Reform Act of 1995. Since this information may contain statements that involve risk and uncertainties and are subject to change at any time, the company's actual results may differ materially from expected results. This document may contain forward-looking statements concerning the Company's operations, current and future performance and financial condition. These items involve risks and uncertainties such as product demand, market and customer acceptance, the effect of economic conditions, competition, pricing, the ability to consummate and integrate acquisitions, and other risks and uncertainties detailed in the Company's SEC filings. The Company undertakes no obligation to revise any of these statements to reflect the future circumstances or the occurrence of unanticipated events.

    For Further Information:
    Product Information                   Shareholder Relations
    Cathy Bradshaw                        Lucy Singleton
    President                             Secretary
    954-315-9242                          817-820-7080


'/>"/>
SOURCE Wound Management Technologies, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Wound Management Technologies, Inc. Announces Agreement with QX Partners, LLC
2. American Biotech Labs(R) Obtains FDA Approval for New Wound Care Gel Product
3. Wounded Warrior Project (WWP) Concerned by Stigma of PTSD and Mental Illness in Military
4. Harris Corporation Donates $10,000 to Wounded Warrior Project during HIMSS09 Healthcare IT Conference and Exposition
5. Wounded Warrior Project (WWP) Applauds Senators Akaka and Burr for Family Caregiver Support Legislation and Pledges to Support the Bill
6. Altrazeal(TM) Clinical Evidence to be Presented at The American Professional Wound Care Association (APWCA) National Clinical Conference 2009
7. Wound, Ostomy & Continence Nurses Society Focuses On Preparing the Next Generation of Leaders
8. Superbug risk to war wounded
9. ACell and Medline Announce Exclusive Marketing and Distribution Agreement for MatriStem(TM) Proprietary Bioscaffold for Wound Care
10. Wound Management Technologies Exhibits at Premier International Diabetic Foot Conference DFCon 09
11. Arobella Medical Announces European CE Mark Approval of Qoustic Wound Therapy System(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... “America On The Brink”: the ... “America On The Brink” is the creation of published author, William Nowers. Captain ... As a WWII veteran, he spent thirty years in the Navy. Following his ...
(Date:10/12/2017)... Francisco, CA (PRWEB) , ... October 12, 2017 ... ... Dr. Cheng, are now treating sleep apnea using cutting-edge Oventus O2Vent ... apnea, a serious sleep disorder characterized by frequent cessation in breathing. Oral appliances ...
(Date:10/12/2017)... ... October 12, 2017 , ... The company has developed a ... and regulatory authorities worldwide. From Children’s to Adults 50+, every formula has been ... standard. , These products are also: Gluten Free, Non-GMO, Vegan, Soy Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics ... PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s ... of Morris F. Collen, a pioneer in the field of medical informatics, this prestigious ...
(Date:10/12/2017)... ... 12, 2017 , ... Information about the technology: , Otomagnetics ... enable prevention of a major side effect of chemotherapy in children. Cisplatin and ... For cisplatin, hearing loss is FDA listed on-label as a dose limiting toxicity. ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... Labs announces the European launch of their new low volume, high ... in Cambridge, U.K on October 4th. The ... with unprecedented speed and sensitivity while using far less sample volume ... ... ...
(Date:9/28/2017)... 2017 Hill-Rom Holdings, Inc. (NYSE: HRC), will ... and webcast on Friday, November 3, 2017, beginning at ... at approximately 8:30 a.m. (CDT) / 9:30 a.m. (EDT). ... financial performance and guidance for 2018, Hill-Rom executives will ... operational performance, and long-range financial outlook through 2020. ...
(Date:9/27/2017)... 27, 2017  Commended for their devotion to personalized service, ... as number one in the South Florida Business Journal,s 50 ... 5000 yearly list, the national specialty pharmacy has found its ... will soon be honored by SFBJ as the 2017 ... Set to receive his award in October, Bardisa said ...
Breaking Medicine Technology: